Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Logan

Showing results (421-430 of 516) with videos related to

Pageof 52
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 26, 2014
Long-term survival after transplantation of unrelated donor peripheral blood or bone marrow hematopoietic cells for hematologic malignancyMary Eapen, Brent R Logan, Fredrick R Appelbaum, et al.
Biochemical and Biophysical Research Communications|November 29, 2007
Vesicle-associated membrane protein 7 (VAMP-7) is essential for target cell killing in a natural killer cell lineMarcelo Marcet-Palacios, Solomon O Odemuyiwa, Jason J Coughlin, et al.
American Journal of Hematology|October 17, 2022
Health-related quality of life in reduced-intensity hematopoietic cell transplantation based on donor availability in patients aged 50-75 with advanced myelodysplastic syndrome: BMT CTN 1102Rachel Cusatis, Michael J Martens, Ryotaro Nakamura, et al.
Blood|March 22, 2007
Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remissionMartin S Tallman, Gordon W Dewald, Sharavi Gandham, et al.
Blood Advances|February 7, 2020
Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trialJennifer M Knight, J Douglas Rizzo, Parameswaran Hari, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2009
The effect of smoking on allogeneic transplant outcomesDavid I Marks, Karen Ballen, Brent R Logan, et al.
Blood|May 16, 2009
Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials NetworkAmin M Alousi, Daniel J Weisdorf, Brent R Logan, et al.
Medical Education Online|May 17, 2025
How much time do internal medicine residents spend on self-directed learning and on which resources: a multi-center studyShreya P Trivedi, Anthony R Artino, Adam Rodman, et al.
Blood|April 19, 2014
Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantationPhilippe Armand, Haesook T Kim, Brent R Logan, et al.
Blood|February 5, 2009
Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor ProgramMichael A Pulsipher, Pintip Chitphakdithai, John P Miller, et al.
Pageof 52

Showing results (421-430 of 516) with videos related to

Sort By:
Pageof 52
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 26, 2014
Long-term survival after transplantation of unrelated donor peripheral blood or bone marrow hematopoietic cells for hematologic malignancyMary Eapen, Brent R Logan, Fredrick R Appelbaum, et al.
Biochemical and Biophysical Research Communications|November 29, 2007
Vesicle-associated membrane protein 7 (VAMP-7) is essential for target cell killing in a natural killer cell lineMarcelo Marcet-Palacios, Solomon O Odemuyiwa, Jason J Coughlin, et al.
American Journal of Hematology|October 17, 2022
Health-related quality of life in reduced-intensity hematopoietic cell transplantation based on donor availability in patients aged 50-75 with advanced myelodysplastic syndrome: BMT CTN 1102Rachel Cusatis, Michael J Martens, Ryotaro Nakamura, et al.
Blood|March 22, 2007
Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remissionMartin S Tallman, Gordon W Dewald, Sharavi Gandham, et al.
Blood Advances|February 7, 2020
Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trialJennifer M Knight, J Douglas Rizzo, Parameswaran Hari, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2009
The effect of smoking on allogeneic transplant outcomesDavid I Marks, Karen Ballen, Brent R Logan, et al.
Blood|May 16, 2009
Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials NetworkAmin M Alousi, Daniel J Weisdorf, Brent R Logan, et al.
Medical Education Online|May 17, 2025
How much time do internal medicine residents spend on self-directed learning and on which resources: a multi-center studyShreya P Trivedi, Anthony R Artino, Adam Rodman, et al.
Blood|April 19, 2014
Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantationPhilippe Armand, Haesook T Kim, Brent R Logan, et al.
Blood|February 5, 2009
Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor ProgramMichael A Pulsipher, Pintip Chitphakdithai, John P Miller, et al.
Pageof 52